References
- Hickie I, Hadzi-Pavlovic D, Ricci C. Reviving the diagnosis of neurasthenia. Psychological Medicine 1997; 27: 989–994
- Chronic fatigue syndrome, G R Bock, J Whelan. Ciba Foundation Symposium, John Wiley, Chichester 1993; 173
- Royal Colleges of Physicians of London. Chronic fatigue syndrome. Report of the Joints Working Group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners, 1996. London 1996
- Wessely S, Hotopf M, Sharpe M. Chronic fatigue and its syndromes. Oxford University Press, New York 1998
- Hickie I B, Scott E M, Davenport T A. Somatic distress: developing more integrated concepts. Current Opinion in Psychiatry 1998; 11: 153–158
- The Royal Australasian College of Physicians. Chronic fatigue syndrome: draft clinical practice guidelines. Medical Journal of Australia 1997, (on website)
- Wilson A, Hickie I, Lloyd A, Wakefield D. Science and speculation: the treatment of chronic fatigue syndrome. American Journal of Medicine 1994; 96: 544–550
- Hickie I, Wilson A. A catecholamine model of fatigue. British Journal of Psychiatry 1994; 165: 275–276
- Vercoulen J HMM, Swanink C MA, Zitman F G, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996; 347: 858–861
- Hickie I, Wilson A, Bennett B, Wright M, Lloyd A, Wakefield D. A double-blind placebo control trial of moclobemide in patients with chronic fatigue syndrome. British Journal of Psychiatry 1998, in press
- White P D, Cleary K J. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome. International Clinical Psychopharmacology 1997; 12: 47–52
- Goldenberg D L, Felson D T, Dinerman A. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis and Rheumatism 1986; 29: 1371–1377
- Moldofsky H. Fibromyalgia, sleep disorder and chronic fatigue syndrome. Chronic fatigue syndrome. Ciba Foundation Symposium, G R Bock, J Whelan. John Wiley, Chichester 1993; 173: 262–271
- Sharpley A L, Williamson D J, Attenburrow M EJ, Pearson G, Sargent P, Cowen P J. The effect of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology 1996; 126: 50–54
- Armitage R, Rush A J, Trivedi M, Cain J, Roffwarg H P. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994; 10: 123–127
- Cohn C K, Robinson D S, Roberts D L, Schwiderski U E, O'Brien K, Ieni J R. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression. Journal of Clinical Psychiatry 1996; 57: 15–18
- Fawcett J, Marcus R N, Anton S F, O'Brien K, Schwiderski U. Response of anxiety and agitation symptoms during nefazodone treatment of major depression. Journal of Clinical Psychiatry 1995; 56: 37–42
- Zajecka J M. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings. Journal of Clinical Psychiatry 1996; 57: 10–14
- Fukuda K, Straus S E, Hickie I, Sharpe M C, Dobbins J G, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 1994; 121: 953–959